drugset / Trial / NCT04221672

The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy

NCT04221672

Phase 3 Unknown 86 enrolled Shanghai Zhongshan Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Portal vein hypertension is associated with post-hepatectomy liver failure in patients with liver cirrhosis. Our previous study found that bolus injection of 1 mg terlipressin immediately after hepatectomy decreased portal vein pressure, and post-operative continuous use of terlipressin decreased the amount of abdominal drain. In this multicenter randomized controlled study, we aim to evaluate the effects of terlipressin in the patients who underwent liver resection complicated by portal vein hypertension.

Timeline

Start
2019-11-07
Primary completion
2020-12-30
Completion
2020-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Terlipressin Peptide 1 mg Intravenous